NDRG3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.073200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.873400E-01
Normal-vs-Stage2
3.191800E-01
Normal-vs-Stage3
1.171030E-01
Normal-vs-Stage4
6.985200E-01
Stage1-vs-Stage2
7.201900E-03
Stage1-vs-Stage3
1.715810E-02
Stage1-vs-Stage4
6.536600E-01
Stage2-vs-Stage3
1.729230E-01
Stage2-vs-Stage4
1.323760E-01
Stage3-vs-Stage4
4.168000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.477600E-01
Normal-vs-AfricanAmerican
2.587200E-01
Normal-vs-Asian
8.452500E-02
Caucasian-vs-AfricanAmerican
6.838400E-01
Caucasian-vs-Asian
6.698000E-02
AfricanAmerican-vs-Asian
2.660000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.617600E-01
Normal-vs-Female
5.303000E-01
Male-vs-Female
7.559400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.448800E-01
Normal-vs-Age(41-60Yrs)
8.844800E-01
Normal-vs-Age(61-80Yrs)
5.092400E-01
Normal-vs-Age(81-100Yrs)
3.563600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.675800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.929000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.459200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.518300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.275600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.833200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.507650E-01
Normal-vs-Daily Drinker
5.648400E-01
Normal-vs-Weekly Drinker
5.134000E-01
Normal-vs-Occasional Drinker
9.127000E-01
Normal-vs-Social Drinker
8.989600E-01
Non Drinker-vs-Daily Drinker
1.163840E-01
Non Drinker-vs-Weekly Drinker
1.811050E-01
Non Drinker-vs-Occasional Drinker
3.272200E-02
Non Drinker-vs-Social Drinker
1.381410E-01
Daily Drinker-vs-Weekly Drinker
9.369800E-01
Daily Drinker-vs-Occasional Drinker
2.622400E-01
Daily Drinker-vs-Social Drinker
5.762200E-01
Weekly Drinker-vs-Occasional Drinker
3.017800E-01
Weekly Drinker-vs-Social Drinker
5.853400E-01
Occasional Drinker-vs-Social Drinker
6.844000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.439800E-01
Normal-vs-Grade 2
7.589800E-01
Normal-vs-Grade 3
7.881600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.551400E-01
Grade 1-vs-Grade 3
1.766360E-01
Grade 1-vs-Grade 4
4.439800E-01
Grade 2-vs-Grade 3
4.813000E-01
Grade 2-vs-Grade 4
7.589800E-01
Grade 3-vs-Grade 4
7.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.524200E-01
Normal-vs-NonDiabetic
6.502200E-01
Diabetic-vs-NonDiabetic
5.826000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.639800E-01
Normal-vs-NoPancreatitis
6.394800E-01
Pancreatitis-vs-NoPancreatitis
8.896400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.102000E-01
Normal-vs-N1
3.598000E-01
N0-vs-N1
1.076370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.232000E-01
Normal-vs-TP53-NonMutant
9.957000E-01
TP53-Mutant-vs-TP53-NonMutant
2.687600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
